This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

The Clinical Trials Industry’s Weekly Update: News, Analysis and Insider Insights Delivered Straight To Your Inbox

Labcorp selects Medidata tech to expand clinical trial capabilities

Share this article

Labcorp Drug Development has signed a deal with Medidata to use its Sensor Cloud platform, which manages a range of sensor and digital health data and establishes interoperability with different clinical data sources.

Under the terms of the deal, Labcorp and Medidata will use Sensor Cloud to co-develop digital biomarkers across various therapeutic areas and medical devices.

Medidata defines digital biomarkers as “objective, quantifiable physiological and behavioral data collected and measured by digital devices such as portable, wearable, implantable, or digestible sensors,” which can then influence and/or predict health-related results.

Both companies aim to build a library of digital markers that can then be used to drive therapeutic research and generate digital diagnostics.

“Use of sensors in clinical research, particularly decentralized clinical trials focused studies, hold the promise of new insights on disease progression, treatment effect and patient quality of life. However, their use is often stymied by technical, operational, and analytical roadblocks that make it difficult for the full benefits to be realized,” Ben Schlatka, vice president, digital biomarker solutions at Medidata told us.

“This collaboration is addressing all three of those issues in pursuit of both broad sensor usage and resultant new digital biomarkers that can expedite new therapies coming to market. Linking popular medical grade sensors to Sensor Cloud allows Medidata and Labcorp to deploy and support these devices in a study - this translates to faster start up times, less risk and better patient experience at the site and at home more readily.”

According to the firm, Sensor Cloud fits with Medidata’s Clinical Cloud. Medidata claims Clinical Cloud is a platform that transforms the clinical trial experience for patients, sponsors, clinical research organizations (CROs), and research sites.

“Labcorp and Medidata believe that not one company is going to invent all of the new, important digital biomarkers. By bringing their respective strengths together in a collaborative fashion, the companies are showing how technology enabled partnerships can offer more to our shared clients and research innovators in terms of both novel technology use (sensors) and new insights that come from them (analytics),” said Schlatka.

The partnership is a multi-year commitment between Labcorp and Medidata.

Image: Stock Photo Secrets

Share this article

Sign up for Clinical Insider email updates